XRAY vs ICUI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
XRAY
ICUI
Investment Advisor Scores
ICUI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XRAY | ICUI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.4627 | 21.3675 | XRAY |
| PEG Ratio | 0.746 | 0.1007 | ICUI |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.1% | 0.5% | ICUI |
| Earnings Growth | 15.2% | -46.9% | XRAY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 57.2/100 | 39.1/100 | XRAY |
| Profit Margin | -15.0% | 1.4% | ICUI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | XRAY |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XRAY
NeutralMixed signals - no dominant trend phase, RSI 36
ICUI
MarkupPrice above SMA50, rising 50-day trend (12.4% over 20 days), RSI 64
Fundamentals Snapshot
| Metric | XRAY | ICUI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.2 | 19.0 |
| Trailing P/E | — | 156.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.1% | 0.1% |
| EPS | -2.71 | 1.17 |
| Dividend Yield | 0.03% | — |